5-(((3-Chloro-4-fluorophenyl)sulfonyl)aminomethyl)-N-((2-methylthiazol-5-yl)methyl)pyrazine-2-carboxamide is a potent GluN2A antagonist; it inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM, shows no inhibition of GluN2B- or GluN2D-mediated responses, and has potential for research in neuropsychiatric and developmental disorders.